MediGene, Abbott sales and marketing update

MediGene disclosed in its 3Q10 earnings that Abbott launched Veregen 10% polyphenon ointment E in Austria to treat genital warts. Last year, MediGene granted Abbott's Solvay Pharmaceuticals rights to...